Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus
Authors:
- Linda OttoboniLOLinda Ottoboni
- Irene Y. FrohlichIFIrene Y. Frohlich
- Michelle LeeMLMichelle Lee
- Brian C. HealyBHBrian C. Healy
- Brendan T. KeenanBKBrendan T. Keenan
- Zongqi XiaZXZongqi Xia
- Tanuja ChitnisTCTanuja Chitnis
- Charles R. GuttmannCGCharles R. Guttmann
- Samia J. KhourySKSamia J. Khoury
- Howard L. WeinerHWHoward L. Weiner
- David A. HaflerDHDavid A. Hafler
- Philip L. De JagerPJPhilip L. De Jager
- 26 November 2013
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 81 (22) , 1891-1899
Abstract
Objective: We set out to characterize the clinical impact and functional consequences of rs1800693G, the multiple sclerosis (MS) susceptibility allele found in the TNFRSF1A locus. Methods: We analyzed prospectively collected data on patients with MS to assess the role of the TNFRSF1A locus on disease course and treatment response. Using archival serum samples and freshly isolated monocytes from patients with MS and healthy subjects, we evaluated the effects of rs1800693G and a second risk allele, R92Q, on immune function. Results: In 772 patients with MS, we see no evidence that rs1800693G strongly influences clinical or radiographic indices of disease course and treatment response; thus, rs1800693G appears to be primarily involved in the onset of MS. At the molecular level, this validated susceptibility allele generates an RNA isoform, TNFRSF1A Δ6, that lacks the transmembrane and cytoplasmic domains. While there was no measurable effect on serum levels of soluble TNFRSF1A, rs1800693G appears to alter the state of monocytes, which demonstrate a more robust transcriptional response of CXCL10 and other genes in response to tumor necrosis factor (TNF)–α. We also report that activation of the TNF-α pathway results in altered expression of 6 other MS susceptibility genes, including T-cell activation rho GTPase activating protein (TAGAP) and regulator of G-protein signaling 1 (RGS1), which are not previously known to be responsive to TNF-α. Conclusions: The MS rs1800693G susceptibility allele affects the magnitude of monocyte responses to TNF-α stimulation, and the TNF pathway may be one network in which the effect of multiple MS genes becomes integrated.Keywords
This publication has 37 references indexed in Scilit:
- TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-JJournal of Experimental Medicine, 2012
- Reactive Oxygen Species and p38 Mitogen-activated Protein Kinase Mediate Tumor Necrosis Factor α-Converting Enzyme (TACE/ADAM-17) Activation in Primary Human MonocytesJournal of Biological Chemistry, 2011
- Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility lociAnnals of Neurology, 2011
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosisNature, 2011
- Genome-wide association study of severity in multiple sclerosisGenes & Immunity, 2011
- Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndromeProceedings of the National Academy of Sciences, 2010
- Type I Interferon: A New Player in TNF Signaling2010
- Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility lociNature Genetics, 2009
- The role of the CD58 locus in multiple sclerosisProceedings of the National Academy of Sciences, 2009
- Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS)Blood, 2006